Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing

Markets GlobeNewswire By GlobeNewswire 12 Nov 2026 13:45 1 min read
Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing

PCI Positions MyGenome as Southeast Asia's Reference Laboratory for Drug Interaction Safety Science PCI Positions MyGenome as Southeast Asia's Reference Laboratory for Drug Interaction Safety Science

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.